Definitions
Sorry, no definitions found. You may find more data at biosimilar.
Etymologies
Sorry, no etymologies found.
Support

Help support Wordnik (and make this page ad-free) by adopting the word Biosimilar.
Examples
-
Related Bills Would Create Regulatory Pathway for Approval of 'Biosimilar' Biologic Therapies
-
"The terms" Biosimilar "or" Follow-on Biologic "refer to products that are marketed after expiration of patents, which are claimed to have similar properties to existing biologic products.
The Medical Quack The Medical Quack 2010
-
Biosimilar sales could rise from $250 million last year to $20 billion by 2020, estimates generics manufacturer Sandoz, a division of pharmaceutical firm Novartis.
Pharmaceutical Industry Is Facing Biological Warfare Hester Plumridge 2010
-
The July 20, 2009 issue of BioCentury has an extensive report on the "Biosimilar fire Drill."
-
Biosimilar drugs are expected to sell at discounts of 25 percent to 45 percent to branded rivals, compared with generic versions of traditional pills that often sell for one-tenth the price of the branded product.
-
A Follow on biologic FOB or Biosimilar, as commonly known, has been one of the most widely discussed topics in the world of pharma in the last few years.
unknown title 2011
-
(OTC: EHSI) expects to reap many benefits from the Biotech industry´s new 12-year haven from Biosimilar competition was included in the healthcare reform legislation passed by the US House of Representatives on Sunday.
American Chronicle American Chronicle 2010
-
Biosimilar Products in the United States and Western Europe marcthollander #intersting - Western Europe places more importance on relationships than US.
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 2010
-
CALGARY, Canada - February 1, 2010 - SemBioSys Genetics Inc. (TSX: SBS) today announced that its Biosimilar Insulin program was featured last night on CTV National News and this morning on Canada AM.
-
Countering Generic and Biosimilar Threats: Near-Term and Long-Term Strategies, the presentation will delve into the study's key findings and case studies of successful near-term generics-defense strategy implementation.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.